Holen Sie sich die Stockscreener-App
118.42
3.69%
-4.54
Handel nachbörslich:
118.42
Axsome Therapeutics Inc Aktie (AXSM) Neueste Nachrichten
Scientech Research LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm - GlobeNewswire
Vident Advisory LLC Acquires New Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Adage Capital Partners GP L.L.C. Sells 12,000 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Woodline Partners LP Cuts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Fred Alger Management LLC Takes $860,000 Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axiom Investors LLC DE Purchases Shares of 26,307 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome initiated with Overweight at Wells Fargo on Alzheimer's drug potential - MSN
Axsome Therapeutics (NASDAQ:AXSM) Director Purchases $200,466.00 in Stock - MarketBeat
Axsome therapeutics director Coleman buys $200k+ in shares - Investing.com India
Axsome therapeutics director Coleman buys $200k+ in shares By Investing.com - Investing.com Australia
Axsome Therapeutics, Inc. $AXSM Shares Sold by Cormorant Asset Management LP - MarketBeat
Ieq Capital LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Will Axsome Therapeutics Inc. announce a stock splitJuly 2025 Sector Moves & Low Risk High Win Rate Picks - Lancaster City Council
Axsome Therapeutics at Morgan Stanley: Strategic Growth and Innovation By Investing.com - Investing.com Canada
Axsome Therapeutics at Morgan Stanley: Strategic Growth and Innovation - Investing.com
Sector ETF Data Correlates with Strength in Axsome Therapeutics Inc.2025 Performance Recap & Safe Entry Point Identification - beatles.ru
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Axsome Therapeutics, Inc. $AXSM is BVF Inc. IL's 2nd Largest Position - MarketBeat
Point72 Europe London LLP Has $1.76 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Russell Investments Group Ltd. Has $308,000 Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
PDT Partners LLC Increases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc2025 Key Lessons & Reliable Breakout Forecasts - Newser
What does recent volatility data suggest for Axsome Therapeutics Inc.July 2025 Analyst Calls & Weekly Stock Breakout Alerts - Newser
Axsome therapeutics director Saad sells $1.14 million in shares By Investing.com - Investing.com Australia
Axsome therapeutics director Saad sells $1.14 million in shares - Investing.com
Ranking Axsome Therapeutics Inc. among high performing stocks via toolsQuarterly Profit Review & High Accuracy Buy Signal Tips - Newser
Applying big data sentiment scoring on Axsome Therapeutics Inc.July 2025 PreEarnings & Weekly High Momentum Picks - Newser
Landscape Capital Management L.L.C. Makes New $632,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Published on: 2025-09-05 14:08:02 - Newser
Is Axsome Therapeutics Inc. a stock for growth or value investorsWeekly Profit Recap & High Conviction Buy Zone Picks - خودرو بانک
Best data tools to analyze Axsome Therapeutics Inc. stockTrade Signal Summary & Technical Pattern Alert System - Newser
Using AI based signals to follow Axsome Therapeutics Inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser
Why Axsome Therapeutics Inc. is moving today2025 Historical Comparison & Smart Investment Allocation Tips - Newser
Custom watchlist performance reports with Axsome Therapeutics Inc.Weekly Investment Report & Fast Entry Momentum Alerts - Newser
Multi asset correlation models including Axsome Therapeutics Inc.Earnings Trend Report & High Conviction Investment Ideas - Newser
Axsome Therapeutics at Cantor Conference: Strategic Growth in Brain Health By Investing.com - Investing.com Canada
Driehaus Capital Management LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics Inc.’s growth already priced inCPI Data & Safe Swing Trade Setup Alerts - khodrobank.com
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years - The Globe and Mail
Will Axsome Therapeutics Inc. bounce back from current supportWeekly Gains Summary & High Return Trade Opportunity Guides - Newser
Forecasting Axsome Therapeutics Inc. price range with options dataJuly 2025 Review & Weekly High Potential Alerts - Newser
Wells Fargo Initiates Coverage on Axsome Therapeutics with Overweight Rating and $163 Price Target - AInvest
Relative strength of Axsome Therapeutics Inc. in sector analysisQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Sector ETF performance correlation with Axsome Therapeutics Inc.Volume Spike & Proven Capital Preservation Methods - Newser
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):